We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 1000kg
Packaging Information: 25kg/drum 1kg/bottle
Delivery Lead Time: 7 days after payment
Sample Provided: yes
Payment Terms: L/L
Product Information
Product name
Nifuratel
CAS No.
4936-47-4
Molecular Formula
C10H11N3O5S
Molecular Weight
285.276
Quality Standard
98.5% up
Appearance
Yellow crystalline powder
COA of Nifuratel
ITEMS
SPECIFICATIONS
RESULTS
Appearance
Yellow crystalline powder
Confirms
Melting Point
186.0 。C - 189.0。C
186.3。C-186.7。C
PH
5.8- 7.4
7.14
Color of solution
Not deeper than No.5
Confirms
Single impurity
≤ 0.1%
0.09%%
Total impurity
≤ 1.0%
0.25%
Loss on drying
≤ 0.5%
0.13%
Residual on ignition
≤ 0.1%
0.03%
Assay
98.5%-101.5%
99.9%
Conclusion
Complies with the enterprise standard
Usage
Function of Nifuratel
Nifuratel is a gynecological antibacterial drug, mainly used for the treatment of bacterial vaginitis, trichomonal vaginitis, candidal vaginitis and vulvitis, in addition to urinary system infections and digestive amebiasis and Giardiasis and so on.
Nifuratel can be quickly absorbed after oral administration. The peak blood concentration can be reached within 2 hours, and there are reports of high concentration in saliva and vaginal secretions. The half-life is 2.75 hours. Nifuratel is also rapidly metabolized, and most of the oral nifuratel is excreted through the kidneys. Together with the two active metabolites, it is excreted in the urine, and the original drug and metabolites can also be excreted in milk. Nifuratel is effective against bacteria, trichomoniasis and candida that cause infections in women's reproductive system. This product mainly inhibits the growth of bacteria by interfering with its enzyme system. It is difficult to penetrate the placenta and has no teratogenic effect.